samedan logo
 
 
 
spacer
home > pmps > summer 2019 > a strong partner from drug discovery to delivery
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Strong Partner from Drug Discovery to Delivery

R&D efforts are of immense importance for the healthcare industry and its successful contribution to human health. However, as the requirements for, and the complexity of, medical solutions are rising, manufacturers face multiple challenges when it comes to the development of new drug solutions. A decisive factor within drug development is testing under real conditions. To ease a high-quality test scenario during drug development, Datwyler launched its Starter Pack solution with SCHOTT.

Drug development is no easy task: from drug discovery through to approval, developing a new medicine takes, on average, 10-15 years and costs around $2.6 billion. Less than 12% of the candidate medicines that make it into Phase I clinical trials are eventually approved by the authorities. The acceleration of new developments in the field of medicine, such as cell and gene therapy, tissue-engineering, and regenerative medicine, will emphasise this trend of increasing complexity. The more dynamic and complex R&D environment results in the involvement of many different stakeholders within the research process (research institutions, CROs, startups, small biotechnology companies, and others). More than ever, players in the healthcare industry are forced to work closely together and rely on strong partnerships to retain their market positions.

To fulfil its expectations as a strong partner in the development and introduction of new drugs, Datwyler launched the Starter Pack, a singlesource solution to support parenteral drug development activities. The new combination of providing packaging components with essential services in one offering was created to support the activity of companies dealing with new parenteral drug development. The Starter Pack provides a complete, robust, readyto- use (RTU) packaging system, easy to order and ready to be globally delivered in small quantities.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global healthcare world. Our state-of-the-art solutions for drug packaging and medical devices build on over 100 years of experience. For more information, visit sealing.datwyler.com
spacer
Datwyler
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PharmaFluidics awarded VLAIO research grant

Ghent, Belgium – June 2, 2020 PharmaFluidics NV, innovative player in the field of analytical chromatography with its unique high-resolution µPAC™ micro-Chip technology, announces that it has been awarded a € 613 k grant from Flanders’ Innovation & Entrepreneurship Agency (VLAIO). The grant will run over two years and will support the further optimization of PharmaFluidics’ manufacturing flow, and to develop complementary new surface-modified µPAC™ products.
More info >>

White Papers

Comparator Sourcing in Oncology Trials

Clinical Services International

This is an exciting time for oncology trials, year on year record numbers of therapeutics are launched and the indications for many drugs on the market are increasing rapidly. Immunotherapies and next generation biotherapeutics are being approved for more tumour types and a growing percentage of the late stage oncology pipeline are targeted biologics.
More info >>

 
Industry Events

CPhI Festival of Pharma

5-16 October 2020, Virtual

A virtual gathering for the pharmaceutical industry, the CPhI Festival of Pharma has been created to fill the gap left by in-person events at a time when travel and gatherings are off the cards.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement